ERBB2 and breast carcinoma: The achievement of pathological complete response (pCR) is a favorable prognostic factor for human epidermal growth factor receptor 2 (HER-2)-positive, triple-negative (TN), and high-grade hormone receptor (HR)-positive HER-2-negative breast cancers [10].